Koers Repros Therapeutics Inc

Aandelen

26-01-18	Repros Announces Negative Opinion From the EMA for Enclomiphene
15-12-17	Repros Therapeutics Inc.® Receives Feedback Following an Oral Explanation with the European Medicines Agency
12-12-17	REPROS THERAPEUTICS INC. Rigrodsky & Long, P.A. Announces Investigation of Buyout
12-12-17	Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Repros Therapeutics Inc. to Allergan plc is Fair to Shareholders
12-12-17	Repros Therapeutics Inc.® Announces Acquisition by Allergan plc

Toevoegen aan een lijst 0 geselecteerde Om deze functie te gebruiken moet u een klant of lid zijn. Inloggen Registreren	Verschil (%)	Varia. 5d.	Varia. 1j.	Varia. 3j.	Kap.($)
REPROS THERAPEUTICS INC	-.--%	+0,74%	-	-	0
LONZA GROUP AG	-0,34%	-0,08%	-12,15%	-13,39%	43,44 mld.
REVOLUTION MEDICINES, INC.	+3,31%	+9,22%	+308,19%	+562,02%	33,54 mld.
IQVIA HOLDINGS INC.	-1,70%	-7,34%	+8,51%	-22,34%	28,48 mld.
BEONE MEDICINES AG	+2,84%	+3,80%	+6,87%	+34,93%	29,2 mld.
CELLTRION, INC.	-0,57%	+4,45%	+12,31%	+20,42%	25,34 mld.
ASCENDIS PHARMA A/S	-0,14%	+7,06%	-	-	14,36 mld.
MEDPACE HOLDINGS, INC.	+0,68%	-3,13%	+52,04%	+107,47%	13,05 mld.
EUROFINS SCIENTIFIC SE	+0,54%	-2,27%	+3,93%	+2,24%	12,67 mld.
IONIS PHARMACEUTICALS, INC.	-0,26%	+0,41%	+100,27%	+80,69%	12,28 mld.
Gemiddelde	+0,44%	+1,38%	+60,00%	+96,51%	23,6 mld.
Gewogen gemiddelde per kap.	+0,60%	+1,40%	+63,25%	+109,05%